Point72 Hong Kong LTD Scholar Rock Holding Corp Transaction History

Point72 Hong Kong LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.66 - $13.96 $14,776 - $44,267	-3,171 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$11.89 - $24.68 $35,170 - $73,003	2,958 Added 1388.73%	3,171 $41,000
Q4 2021 Feb 14, 2022	BUY	$24.14 - $35.18 $5,141 - $7,493	213 New	213 $5,000
Q3 2021 Nov 15, 2021	SELL	$27.38 - $42.21 $31,487 - $48,541	-1,150 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$26.34 - $46.62 $30,291 - $53,613	1,150 New	1,150 $33,000
Q2 2020 Aug 14, 2020	SELL	$10.37 - $20.64 $3,463 - $6,893	-334 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$9.63 - $17.14 $3,216 - $5,724	334 New	334 $4,000

175

75.6M

585K

862K

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $2.17B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.